Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1996 Jun;5(3):224–229. doi: 10.1155/S0962935196000324

Effects of fluticasone propionate on arachidonic acid metabolites in BAL-fluid and methacholine dose-response curves in non-smoking atopic asthmatics

S E Overbeek 1,✉, J M Bogaard 1, I M Garrelds 2, F J Zijlstra 2, P G H Mulder 3, H C Hoogsteden 1
PMCID: PMC2365791  PMID: 18475721

Abstract

Hyperresponsiveness of the airways to nonspecific stimuli is a characteristic feature of asthma. Airway responsiveness is usually characterized in terms of the position and shape of the dose–response curve to methacholine (MDR). In the study we have investigated the influence of fluticasone propionate (FP), a topically active glucocorticoid, on arachidonic acid (AA) metabolites in broncho-alveolar lavage (BAL) fluid (i.e. TxB2, PGE2, PGD2, 6kPGF1α and LTC4) on the one hand and MDR curves on the other hand. The effect of FP was studied in a randomized, double-blind, placebo-controlled design in 33 stable nonsmoking asthmatics; 16 patients received FP (500 μg b.i.d.) whereas 17 patients were treated with placebo. We found that the forced expiratory volume in 1s (FEV1 % predicted) increased, the log2PC20 methacholine increased and the plateau value (% fall in FEV1) decreased after a 12 week treatment period. No changes in AA-metabolites could be determined after treatment except for PGD2 which decreased nearly significantly (p = 0.058) within the FP treated group, whereas the change of PGD2 differed significantly (p = 0.05) in the FP treated group from placebo. The levels of the other AA metabolites (i.e. TxB2, PGE2, 6kPGF1α and LTC4) remained unchanged after treatment and were not significantly different from the placebo group. Our results support the hypothesis that although FP strongly influences the position, the shape and also the maximum response plateau of the MDR curve, this effect is not mainly achieved by influence on the level of AA metabolites. Other pro-inflammatory factors may be of more importance for the shape of the MDR curve. It is suggested that these pro-inflammatory factors are downregulated by FP.

Full Text

The Full Text of this article is available as a PDF (677.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aerts J. G., Bogaard J. M., Overbeek S. E., Verbraak A. F., Thio P. Extrapolation of methacholine log-dose response curves with a Cumulative Gaussian Distribution function. Eur Respir J. 1994 May;7(5):895–900. [PubMed] [Google Scholar]
  2. Arm J. P., Lee T. H. The pathobiology of bronchial asthma. Adv Immunol. 1992;51:323–382. doi: 10.1016/s0065-2776(08)60491-5. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. J. Neural control of human airways in health and disease. Am Rev Respir Dis. 1986 Dec;134(6):1289–1314. doi: 10.1164/arrd.1986.134.5.1289. [DOI] [PubMed] [Google Scholar]
  4. Bel E. H., Timmers M. C., Hermans J., Dijkman J. H., Sterk P. J. The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. Am Rev Respir Dis. 1990 Jan;141(1):21–28. doi: 10.1164/ajrccm/141.1.21. [DOI] [PubMed] [Google Scholar]
  5. Bel E. H., Timmers M. C., Zwinderman A. H., Dijkman J. H., Sterk P. J. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects. Am Rev Respir Dis. 1991 Jan;143(1):109–113. doi: 10.1164/ajrccm/143.1.109. [DOI] [PubMed] [Google Scholar]
  6. Bel E. H., van der Veen H., Dijkman J. H., Sterk P. J. The effect of inhaled budesonide on the maximal degree of airway narrowing to leukotriene D4 and methacholine in normal subjects in vivo. Am Rev Respir Dis. 1989 Feb;139(2):427–431. doi: 10.1164/ajrccm/139.2.427. [DOI] [PubMed] [Google Scholar]
  7. Bel E. H., van der Veen H., Kramps J. A., Dijkman J. H., Sterk P. J. Maximal airway narrowing to inhaled leukotriene D4 in normal subjects. Comparison and interaction with methacholine. Am Rev Respir Dis. 1987 Oct;136(4):979–984. doi: 10.1164/ajrccm/136.4.979. [DOI] [PubMed] [Google Scholar]
  8. Christie P. E., Yntema J. L., Tagari P., Ysselstijn H., Ford-Hutchinson A. W., Lee T. H. Effect of altitude on urinary leukotriene (LT) E4 excretion and airway responsiveness to histamine in children with atopic asthma. Eur Respir J. 1995 Mar;8(3):357–363. doi: 10.1183/09031936.95.08030357. [DOI] [PubMed] [Google Scholar]
  9. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977 May;7(3):235–243. doi: 10.1111/j.1365-2222.1977.tb01448.x. [DOI] [PubMed] [Google Scholar]
  10. Dworski R., Fitzgerald G. A., Oates J. A., Sheller J. R. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med. 1994 Apr;149(4 Pt 1):953–959. doi: 10.1164/ajrccm.149.4.8143061. [DOI] [PubMed] [Google Scholar]
  11. Fleming W. W., McPhillips J. J., Westfall D. P. Postjunctional supersensitivity and subsensitivity of excitable tissues to drugs. Ergeb Physiol. 1973;68:55–119. doi: 10.1007/3-540-06238-6_5. [DOI] [PubMed] [Google Scholar]
  12. Fuller R. W., Dixon C. M., Dollery C. T., Barnes P. J. Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis. 1986 Feb;133(2):252–254. doi: 10.1164/arrd.1986.133.2.252. [DOI] [PubMed] [Google Scholar]
  13. Laitinen L. A., Laitinen A., Haahtela T., Vilkka V., Spur B. W., Lee T. H. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet. 1993 Apr 17;341(8851):989–990. doi: 10.1016/0140-6736(93)91073-u. [DOI] [PubMed] [Google Scholar]
  14. Laitinen L. A., Laitinen A. Mucosal inflammation and bronchial hyperreactivity. Eur Respir J. 1988 May;1(5):488–489. [PubMed] [Google Scholar]
  15. Leff A. R. Endogenous regulation of bronchomotor tone. Am Rev Respir Dis. 1988 May;137(5):1198–1216. doi: 10.1164/ajrccm/137.5.1198. [DOI] [PubMed] [Google Scholar]
  16. Liu M. C., Hubbard W. C., Proud D., Stealey B. A., Galli S. J., Kagey-Sobotka A., Bleecker E. R., Lichtenstein L. M. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis. 1991 Jul;144(1):51–58. doi: 10.1164/ajrccm/144.1.51. [DOI] [PubMed] [Google Scholar]
  17. MacDermot J., Kelsey C. R., Waddell K. A., Richmond R., Knight R. K., Cole P. J., Dollery C. T., Landon D. N., Blair I. A. Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. Prostaglandins. 1984 Feb;27(2):163–179. doi: 10.1016/0090-6980(84)90071-6. [DOI] [PubMed] [Google Scholar]
  18. Moreno R. H., Hogg J. C., Paré P. D. Mechanics of airway narrowing. Am Rev Respir Dis. 1986 Jun;133(6):1171–1180. doi: 10.1164/arrd.1986.133.6.1171. [DOI] [PubMed] [Google Scholar]
  19. Neijens H. J., Degenhart H. J., Raatgeep R., Kerrebijn K. F. The correlation between increased reactivity of the bronchi and of mediator releasing cells in asthma. Clin Allergy. 1980 Sep;10(5):535–539. doi: 10.1111/j.1365-2222.1980.tb02134.x. [DOI] [PubMed] [Google Scholar]
  20. O'Shaughnessy K. M., Wellings R., Gillies B., Fuller R. W. Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion. Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1472–1476. doi: 10.1164/ajrccm/147.6_Pt_1.1472. [DOI] [PubMed] [Google Scholar]
  21. Oosterhoff Y., Overbeek S. E., Douma R., Noordhoek J. A., Postma D. S., Hoogsteden H. C., Zijlstra F. J. Lower leukotriene C(4) levels in bronchoalveolar lavage fluid of asthmatic subjects after 2.5 years of inhaled corticosteroid therapy. Mediators Inflamm. 1995;4(6):426–430. doi: 10.1155/S0962935195000688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sterk P. J., Bel E. H. Bronchial hyperresponsiveness: the need for a distinction between hypersensitivity and excessive airway narrowing. Eur Respir J. 1989 Mar;2(3):267–274. [PubMed] [Google Scholar]
  23. Sterk P. J., Daniel E. E., Zamel N., Hargreave F. E. Limited bronchoconstriction to methacholine using partial flow-volume curves in nonasthmatic subjects. Am Rev Respir Dis. 1985 Aug;132(2):272–277. doi: 10.1164/arrd.1985.132.2.272. [DOI] [PubMed] [Google Scholar]
  24. Tamaoki J., Sekizawa K., Graf P. D., Nadel J. A. Cholinergic neuromodulation by prostaglandin D2 in canine airway smooth muscle. J Appl Physiol (1985) 1987 Oct;63(4):1396–1400. doi: 10.1152/jappl.1987.63.4.1396. [DOI] [PubMed] [Google Scholar]
  25. Taylor G. W., Taylor I., Black P., Maltby N. H., Turner N., Fuller R. W., Dollery C. T. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet. 1989 Mar 18;1(8638):584–588. doi: 10.1016/s0140-6736(89)91611-5. [DOI] [PubMed] [Google Scholar]
  26. Wardlaw A. J., Dunnette S., Gleich G. J., Collins J. V., Kay A. B. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis. 1988 Jan;137(1):62–69. doi: 10.1164/ajrccm/137.1.62. [DOI] [PubMed] [Google Scholar]
  27. Wenzel S. E., Larsen G. L., Johnston K., Voelkel N. F., Westcott J. Y. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis. 1990 Jul;142(1):112–119. doi: 10.1164/ajrccm/142.1.112. [DOI] [PubMed] [Google Scholar]
  28. Wenzel S. E., Westcott J. Y., Smith H. R., Larsen G. L. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis. 1989 Feb;139(2):450–457. doi: 10.1164/ajrccm/139.2.450. [DOI] [PubMed] [Google Scholar]
  29. Westcott J. Y., Voelkel N. F., Jones K., Wenzel S. E. Inactivation of leukotriene C4 in the airways and subsequent urinary leukotriene E4 excretion in normal and asthmatic subjects. Am Rev Respir Dis. 1993 Nov;148(5):1244–1251. doi: 10.1164/ajrccm/148.5.1244. [DOI] [PubMed] [Google Scholar]
  30. Woolcock A. J., Salome C. M., Yan K. The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis. 1984 Jul;130(1):71–75. doi: 10.1164/arrd.1984.130.1.71. [DOI] [PubMed] [Google Scholar]
  31. Zijlstra F. J., Vincent J. E., Mol W. M., Hoogsteden H. C., Van Hal P. T., Jongejan R. C. Eicosanoid levels in bronchoalveolar lavage fluid of young female smokers and non-smokers. Eur J Clin Invest. 1992 May;22(5):301–306. doi: 10.1111/j.1365-2362.1992.tb01466.x. [DOI] [PubMed] [Google Scholar]
  32. de Jongste J. C., Mons H., Bonta I. L., Kerrebijn K. F. In vitro responses of airways from an asthmatic patient. Eur J Respir Dis. 1987 Jul;71(1):23–29. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES